Alembic Pharmaceuticals gets EIR for Solid Oral Formulation Facility (F-4) at Vadodara

10 May 2023 Evaluate

Alembic Pharmaceuticals has received an Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at company’s Solid Oral Formulation Facility (F-4) at Jarod, Vadodara during the period from December 08, 2022 to December 16, 2022. This was pre-approval inspection to cover Solid Oral drug products for which ANDAs were filed with USFDA. The Company had also started receiving approvals manufactured at this facility.

Alembic has a total of five drug product manufacturing facilities and two drug substance manufacturing facilities. All these facilities are inspected and accepted by USFDA. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Alembic Pharma Share Price

1041.80 3.60 (0.35%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.